A patient had apical hypertrophic cardiomyopathy and left atrial myxoma. We believe that this is the first description of such a combination.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1378/chest.101.4.1149 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Role of Genetic Testing in Diagnosis and Prognosis Prediction in Hypertrophic Cardiomyopathy in Korea.
J Korean Med Sci
December 2024
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
Background: Hypertrophic cardiomyopathy (HCM) needs careful differentiation from other cardiomyopathies. Current guidelines recommend genetic testing, but genetic data on differential diagnoses and their relation with clinical outcomes in HCM are still lacking. This study aimed to investigate the prevalence of genetic variants and the proportion of other cardiomyopathies in patients with suspected HCM in Korea and compare the outcomes of HCM according to the presence of sarcomere gene mutation.
View Article and Find Full Text PDFProgress in the Clinical Application of Artificial Intelligence for Left Ventricle Analysis in Cardiac Magnetic Resonance.
Rev Cardiovasc Med
December 2024
Department of Radiology, Beijing Friendship Hospital, Capital Medical University, 100050 Beijing, China.
Cardiac magnetic resonance (CMR) imaging enables a one-stop assessment of heart structure and function. Artificial intelligence (AI) can simplify and automate work flows and improve image post-processing speed and diagnostic accuracy; thus, it greatly affects many aspects of CMR. This review highlights the application of AI for left heart analysis in CMR, including quality control, image segmentation, and global and regional functional assessment.
View Article and Find Full Text PDFEchocardiographic Changes Following Surgical Myectomy in Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy: Insights From the SPIRIT-HCM Study.
J Am Heart Assoc
January 2025
Hypertrophic Cardiomyopathy Center, Heart, Vascular and Thoracic Institute Cleveland Clinic Cleveland OH USA.
Background: In obstructive hypertrophic cardiomyopathy, myectomy improves symptoms, quality of life, and left ventricular (LV) outflow tract gradients. We prospectively evaluated the temporal changes in various echo parameters after myectomy.
Methods And Results: In 173 adults with obstructive hypertrophic cardiomyopathy (53±10 years, 63% men) who underwent myectomy between March 2017 and June 2020, clinical and blinded echo assessment (before and at 12±6 months follow-up) was performed prospectively (SPIRIT-HCM [Quality of Life and Functional Capacity Following Septal Myectomy in Obstructive Patients With Hypertrophic Cardiomyopathy]).
Echocardiographic red flags of ATTR cardiomyopathy a single centre validation.
Eur Heart J Imaging Methods Pract
July 2024
Departments of Diagnostics and Intervention, Clinical Physiology, Umeå University, 907 37 Umeå, Sweden.
Aims: Echocardiography plays an important role in suspecting the presence of transthyretin cardiomyopathy (ATTR-CM) in patients with heart failure, based on parameters proposed as 'red flags' for the diagnosis of ATTR-CM. We aimed to validate those measurements in a group of patients with ATTR-CM including ATTRv and ATTRwt.
Methods And Results: We tested a number of echocardiographic red flags in 118 patients with confirmed diagnosis of ATTR-CM.
Surgical management of apical aneurysm in hypertrophic cardiomyopathy.
Asian J Surg
December 2024
Jiujiang CityKey Laboratory of Cell Therapy, Jiujiang NO.1 People's Hospital, Jiujiang, Jiangxi, 332000, China; Department of Cardiology, Jiujiang NO.1 People's Hospital, Jiujiang, Jiangxi, 332000, China. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!